Harm Reduction: A History of Meeting People Where They Are

What Is Harm Reduction?

Harm reduction is a public health approach to addiction that focuses on reducing the negative consequences of substance use — rather than requiring abstinence as a precondition for help. It is based on the recognition that many people who use substances are not ready or able to stop immediately, and that reducing the harm associated with their use — preventing overdose, reducing disease transmission, improving health — is a legitimate and important goal even in the absence of abstinence.

Harm reduction is sometimes portrayed as being in opposition to abstinence-based recovery. This is a false dichotomy. Harm reduction and abstinence-based recovery are complementary approaches that serve different people at different points in their relationship with substances. Many people who initially engage with harm reduction services eventually achieve abstinence. And many people in abstinence-based recovery benefit from harm reduction tools — including naloxone, which can save their life if they relapse. The goal of harm reduction is not to enable drug use, but to keep people alive and healthy long enough to access treatment and achieve recovery.

The harm reduction movement has its roots in the pragmatic public health tradition — the recognition that the perfect should not be the enemy of the good, and that reducing harm is a legitimate goal even when elimination of the harmful behavior is not immediately achievable. This pragmatic orientation has made harm reduction controversial in some quarters, but it has also made it one of the most effective public health approaches to addiction.

Origins: The HIV Epidemic and Needle Exchange

The modern harm reduction movement emerged in the Netherlands in the 1980s, in response to the HIV epidemic among people who inject drugs. The first needle exchange program — providing clean syringes to people who inject drugs to prevent the sharing of needles that transmits HIV and hepatitis C — was established in Amsterdam in 1984. The program was controversial, but its effectiveness in reducing HIV transmission was quickly demonstrated, and it spread rapidly across Europe.

The logic of needle exchange is straightforward: if people are going to inject drugs regardless of whether clean needles are available, providing clean needles reduces the transmission of HIV and hepatitis C without increasing drug use. Multiple studies have confirmed this logic — needle exchange programs reduce HIV and hepatitis C transmission without increasing drug use, and they often serve as a point of contact through which people who use drugs can access treatment and other health services.

In the United States, the harm reduction movement faced significant political resistance. The first needle exchange programs in the U.S. were established in the late 1980s by activists who operated them illegally, in defiance of laws that prohibited the distribution of drug paraphernalia. The federal government banned the use of federal funds for needle exchange programs — a ban that was not fully lifted until 2016. This political resistance cost lives: the HIV epidemic among people who inject drugs in the United States was significantly worse than it needed to be because of the delay in implementing needle exchange programs.

Methadone Maintenance: The Original MAT

Methadone maintenance treatment, which was developed in the 1960s by Vincent Dole and Marie Nyswander, was one of the earliest and most significant harm reduction interventions. Dole and Nyswander demonstrated that providing daily doses of methadone to people with opioid use disorder dramatically reduced illicit opioid use, criminal activity, and HIV transmission, while improving social functioning and quality of life.

Methadone maintenance was controversial from the beginning. Critics argued that it was simply substituting one addiction for another — that people on methadone were not truly in recovery. This criticism reflected a misunderstanding of both addiction and recovery. Methadone maintenance does not produce the euphoria of heroin or other short-acting opioids; it stabilizes the person's neurochemistry and allows them to function normally. People on methadone can work, maintain relationships, and participate in their communities in ways that are impossible when they are in the grip of active opioid addiction.

The evidence for methadone maintenance is overwhelming. It reduces opioid overdose mortality by 50 percent or more, reduces HIV transmission, reduces criminal activity, and improves social functioning. It is one of the most effective medical interventions for any chronic disease, and the resistance to it — which has been driven by stigma and moral objections rather than evidence — has cost countless lives.

Naloxone Distribution

The most significant harm reduction intervention of the opioid crisis era has been the widespread distribution of naloxone — the medication that reverses opioid overdose. Naloxone has been available since the 1960s, but for most of its history it was available only in medical settings. The harm reduction movement advocated for making naloxone available to people who use opioids and their families, so that overdoses could be reversed before emergency services arrived.

The campaign to expand naloxone access was driven by harm reduction advocates who recognized that overdose was the most immediate and preventable consequence of opioid use disorder. They argued — correctly — that making naloxone available to people who use opioids and their families would save lives without increasing drug use. Multiple studies have confirmed this: naloxone distribution programs reduce overdose mortality without increasing drug use.

Today, naloxone is available without a prescription in most U.S. states, and its widespread distribution has saved hundreds of thousands of lives. The naloxone distribution movement is one of the clearest examples of harm reduction's life-saving potential. The development of intranasal naloxone (Narcan nasal spray) has made it even more accessible, allowing anyone — not just healthcare providers — to administer it quickly and effectively.

Fentanyl Test Strips

The emergence of illicitly manufactured fentanyl in the drug supply has created a new harm reduction challenge. Fentanyl is 50 to 100 times more potent than morphine, and a dose that is invisible to the naked eye can be lethal. People who use drugs may not know they are consuming fentanyl, and a single dose can kill someone who has no tolerance to opioids.

Fentanyl test strips, which can detect the presence of fentanyl in a drug supply, are an important harm reduction tool that can save lives. Studies have shown that people who use fentanyl test strips are more likely to take precautions when fentanyl is detected — using less, using with others, or not using at all. Despite their life-saving potential, fentanyl test strips are classified as drug paraphernalia in many states, limiting their availability.

Supervised Consumption Sites

The most controversial harm reduction intervention is the supervised consumption site — a facility where people can use pre-obtained drugs under medical supervision, with immediate access to overdose reversal and other health services. Supervised consumption sites have been operating in Canada, Europe, and Australia for decades, with strong evidence of effectiveness in reducing overdose deaths and connecting people with treatment services.

The evidence from supervised consumption sites is compelling. Studies have found that they reduce overdose deaths in the surrounding area, reduce emergency room visits for overdose, reduce HIV and hepatitis C transmission, and connect people with treatment services. No one has ever died of an overdose inside a supervised consumption site. The first legally sanctioned supervised consumption sites in the United States opened in New York City in 2021, and their early results have been consistent with the international evidence.

Harm Reduction and Recovery

The harm reduction movement has made important contributions to the recovery landscape beyond its specific interventions. It has helped shift the conversation about addiction from moral condemnation to public health. It has demonstrated that meeting people where they are — without requiring abstinence as a precondition for help — is both effective and humane. And it has helped reduce the stigma that prevents people from seeking help, by treating people who use substances with dignity and respect rather than judgment.

The harm reduction movement and the recovery movement are not in opposition — they are partners in the effort to reduce the suffering caused by addiction. Harm reduction keeps people alive and healthy long enough to access recovery. Recovery provides the meaning, connection, and purpose that make sustained sobriety possible. Together, they represent a comprehensive approach to addiction that honors both the immediate need to reduce harm and the long-term goal of full recovery.